A psychiatric patient with bipolar mood disorder has been taking lithium carbonate for a long time. Which of the following blood parameters should be regularly monitored, EXCEPT?

1. A

   Kidney function tests

2. B

   Thyroid function tests

3. C

   Electrolyte levels

4. D

   Liver function test

Appeared in: NORCERT 8 Mains-2025

Explanation

Listen in Hindi

• Lithium carbonate is not metabolized by the liver; it is almost entirely excreted unchanged by the kidneys.
• Therefore, hepatotoxicity (liver damage) is not a common or expected side effect, and routine monitoring of liver function tests (LFTs) is not standard practice for lithium therapy.
• Monitoring LFTs is standard for other mood stabilizers like valproic acid, which is known to be hepatotoxic, but not for lithium unless a co-existing liver condition is present.

Why Other Options Were Wrong

• Option A: Lithium is cleared almost exclusively by the kidneys. Long-term use can lead to nephrotoxicity, including nephrogenic diabetes insipidus and chronic interstitial nephritis. Regular monitoring of BUN and creatinine is essential to prevent lithium toxicity.
• Option B: Lithium interferes with the synthesis and release of thyroid hormones, often leading to hypothyroidism and goiter. Regular monitoring of Thyroid-Stimulating Hormone (TSH) is mandatory to detect thyroid dysfunction early.
• Option C: Lithium is a salt, and its renal clearance is highly dependent on sodium levels. Low sodium (hyponatremia), often caused by dehydration, excessive sweating, or diuretics, can decrease lithium excretion and lead to toxic levels. Therefore, monitoring electrolytes is crucial.

Related Visual

• Visual 1: Infographic: A diagram showing the primary organs affected by lithium (kidneys, thyroid gland) and the corresponding blood tests (BUN/Creatinine, TSH). This visual helps reinforce the key monitoring points.
• Visual 2: Table: A comparison table of monitoring parameters for different mood stabilizers (Lithium vs. Valproic Acid vs. Carbamazepine), highlighting that LFTs are required for valproate/carbamazepine but not lithium.

Clinical Relevance

• Nursing practice connection: Use the key finding related to Pharmacological management of bipolar disorder and associated laboratory monitoring for lithium therapy to guide bedside assessment, documentation, and the next nursing action.
• Nurses play a vital role in educating patients on lithium about the importance of maintaining consistent salt and fluid intake (2-3 L/day) to ensure stable therapeutic levels and prevent toxicity.
• Recognizing and teaching the patient to report early signs of lithium toxicity (e.g., coarse hand tremors, nausea, vomiting, ataxia, confusion) is a critical nursing responsibility that requires prompt reporting and intervention.
• What if? If a patient on lithium is prescribed a diuretic (e.g., hydrochlorothiazide) for hypertension, the nurse must anticipate an increased risk of lithium toxicity. Diuretics promote sodium loss, which causes the kidneys to retain more lithium, necessitating more frequent level checks and a potential dose reduction.

How to Approach the Question

• First, identify the keyword 'EXCEPT'. This signals that three of the options are necessary monitoring parameters, and you must find the one that is not.
• Second, recall the core pharmacology of lithium carbonate. The most important facts are its narrow therapeutic index and its primary route of excretion.
• Think about how lithium is handled by the body: it is a salt, it is not processed by the liver, it is cleared by the kidneys, and it is known to affect the thyroid gland.
• Evaluate each option based on this knowledge: Kidney tests? Yes, due to renal excretion and potential for nephrotoxicity. Thyroid tests? Yes, due to its common side effect of hypothyroidism. Electrolytes? Yes, because its level is directly linked to sodium balance.
• This process of elimination leaves 'Liver function test'. Since lithium is not metabolized by the liver, routine LFTs are not necessary, making it the correct answer to this 'EXCEPT' question.

Concept Tested & Keywords

• Concept Tested: Pharmacological management of bipolar disorder and associated laboratory monitoring for lithium therapy.
• Stem keywords: lithium carbonate, bipolar mood disorder, long time, regularly monitored
• Lead-in keywords: EXCEPT
• Negative lead-in flag: The question asks to identify the test that is NOT required, which is a negative framing.

Question ID

QLB2jkHuP9dtGZggO6VbEf

Copy ID